HEALTHPEAK PROPERTIES INC (DOC) Fundamental Analysis & Valuation

NYSE:DOC • US42250P1030

Current stock price

17.3 USD
+0.25 (+1.47%)
Last:

This DOC fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. DOC Profitability Analysis

1.1 Basic Checks

  • DOC had positive earnings in the past year.
  • In the past year DOC had a positive cash flow from operations.
  • DOC had positive earnings in each of the past 5 years.
  • DOC had a positive operating cash flow in each of the past 5 years.
DOC Yearly Net Income VS EBIT VS OCF VS FCFDOC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M -500M 1B -1B

1.2 Ratios

  • DOC has a Return On Assets of 0.35%. This is comparable to the rest of the industry: DOC outperforms 47.15% of its industry peers.
  • DOC's Return On Equity of 0.94% is in line compared to the rest of the industry. DOC outperforms 49.59% of its industry peers.
  • DOC's Return On Invested Capital of 2.24% is in line compared to the rest of the industry. DOC outperforms 40.65% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for DOC is in line with the industry average of 3.13%.
Industry RankSector Rank
ROA 0.35%
ROE 0.94%
ROIC 2.24%
ROA(3y)1.17%
ROA(5y)1.99%
ROE(3y)2.87%
ROE(5y)4.76%
ROIC(3y)2.27%
ROIC(5y)2.16%
DOC Yearly ROA, ROE, ROICDOC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • DOC has a Profit Margin (2.50%) which is comparable to the rest of the industry.
  • DOC's Profit Margin has declined in the last couple of years.
  • DOC has a Operating Margin of 19.31%. This is comparable to the rest of the industry: DOC outperforms 46.34% of its industry peers.
  • DOC's Operating Margin has improved in the last couple of years.
  • DOC has a Gross Margin of 60.00%. This is in the lower half of the industry: DOC underperforms 68.29% of its industry peers.
  • In the last couple of years the Gross Margin of DOC has grown nicely.
Industry RankSector Rank
OM 19.31%
PM (TTM) 2.5%
GM 60%
OM growth 3Y0.32%
OM growth 5Y7.81%
PM growth 3Y-53.06%
PM growth 5Y-36.91%
GM growth 3Y1.1%
GM growth 5Y2.84%
DOC Yearly Profit, Operating, Gross MarginsDOC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. DOC Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so DOC is destroying value.
  • DOC has less shares outstanding than it did 1 year ago.
  • The number of shares outstanding for DOC has been increased compared to 5 years ago.
  • DOC has a worse debt/assets ratio than last year.
DOC Yearly Shares OutstandingDOC Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M
DOC Yearly Total Debt VS Total AssetsDOC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B

2.2 Solvency

  • Based on the Altman-Z score of 0.34, we must say that DOC is in the distress zone and has some risk of bankruptcy.
  • DOC has a Altman-Z score (0.34) which is in line with its industry peers.
  • A Debt/Equity ratio of 1.27 is on the high side and indicates that DOC has dependencies on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 1.27, DOC is in line with its industry, outperforming 49.59% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.27
Debt/FCF N/A
Altman-Z 0.34
ROIC/WACC0.37
WACC6.04%
DOC Yearly LT Debt VS Equity VS FCFDOC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B 6B 8B

2.3 Liquidity

  • A Current Ratio of 0.48 indicates that DOC may have some problems paying its short term obligations.
  • With a Current ratio value of 0.48, DOC is not doing good in the industry: 74.80% of the companies in the same industry are doing better.
  • DOC has a Quick Ratio of 0.48. This is a bad value and indicates that DOC is not financially healthy enough and could expect problems in meeting its short term obligations.
  • DOC has a Quick ratio of 0.48. This is in the lower half of the industry: DOC underperforms 74.80% of its industry peers.
Industry RankSector Rank
Current Ratio 0.48
Quick Ratio 0.48
DOC Yearly Current Assets VS Current LiabilitesDOC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. DOC Growth Analysis

3.1 Past

  • DOC shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by 0.00%.
  • Measured over the past years, DOC shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -16.06% on average per year.
  • Looking at the last year, DOC shows a small growth in Revenue. The Revenue has grown by 4.52% in the last year.
  • DOC shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.40% yearly.
EPS 1Y (TTM)0%
EPS 3Y-27.44%
EPS 5Y-16.06%
EPS Q2Q%1500%
Revenue 1Y (TTM)4.52%
Revenue growth 3Y11.05%
Revenue growth 5Y11.4%
Sales Q2Q%3.07%

3.2 Future

  • DOC is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 0.77% yearly.
  • The Revenue is expected to grow by 5.62% on average over the next years.
EPS Next Y-37.96%
EPS Next 2Y-16.2%
EPS Next 3Y-9.72%
EPS Next 5Y0.77%
Revenue Next Year1.94%
Revenue Next 2Y3.03%
Revenue Next 3Y4.42%
Revenue Next 5Y5.62%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
DOC Yearly Revenue VS EstimatesDOC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 1B 2B 3B 4B
DOC Yearly EPS VS EstimatesDOC Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0.5 1 1.5 2

More info and screens

Find the best growth stocksShow best growing peers

1

4. DOC Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 49.43, the valuation of DOC can be described as expensive.
  • DOC's Price/Earnings is on the same level as the industry average.
  • When comparing the Price/Earnings ratio of DOC to the average of the S&P500 Index (25.23), we can say DOC is valued expensively.
  • With a Price/Forward Earnings ratio of 79.67, DOC can be considered very expensive at the moment.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of DOC is on the same level as its industry peers.
  • DOC is valuated expensively when we compare the Price/Forward Earnings ratio to 22.42, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 49.43
Fwd PE 79.67
DOC Price Earnings VS Forward Price EarningsDOC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, DOC is valued a bit cheaper than the industry average as 60.16% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 13.24
DOC Per share dataDOC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

  • DOC's earnings are expected to decrease with -9.72% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-16.2%
EPS Next 3Y-9.72%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. DOC Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 6.88%, DOC is a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 7.32, DOC pays a bit more dividend than its industry peers.
  • Compared to an average S&P500 Dividend Yield of 1.89, DOC pays a better dividend.
Industry RankSector Rank
Dividend Yield 6.88%

5.2 History

  • The dividend of DOC decreases each year by -4.20%.
  • DOC has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)-4.2%
Div Incr Years0
Div Non Decr Years0
DOC Yearly Dividends per shareDOC Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2 2.5

5.3 Sustainability

  • 1204.15% of the earnings are spent on dividend by DOC. This is not a sustainable payout ratio.
DP1204.15%
EPS Next 2Y-16.2%
EPS Next 3Y-9.72%
DOC Yearly Income VS Free CF VS DividendDOC Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M -500M 1B -1B
DOC Dividend Payout.DOC Dividend Payout, showing the Payout Ratio.DOC Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

DOC Fundamentals: All Metrics, Ratios and Statistics

HEALTHPEAK PROPERTIES INC

NYSE:DOC (3/23/2026, 11:50:09 AM)

17.3

+0.25 (+1.47%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)02-02
Earnings (Next)04-22
Inst Owners97.68%
Inst Owner Change-96.4%
Ins Owners0.23%
Ins Owner Change1.26%
Market Cap12.03B
Revenue(TTM)2.82B
Net Income(TTM)70.51M
Analysts73.91
Price Target19.83 (14.62%)
Short Float %4.64%
Short Ratio3.46
Dividend
Industry RankSector Rank
Dividend Yield 6.88%
Yearly Dividend1.22
Dividend Growth(5Y)-4.2%
DP1204.15%
Div Incr Years0
Div Non Decr Years0
Ex-Date03-17
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)108.65%
Min EPS beat(2)37.75%
Max EPS beat(2)179.54%
EPS beat(4)3
Avg EPS beat(4)52.57%
Min EPS beat(4)-19.41%
Max EPS beat(4)179.54%
EPS beat(8)5
Avg EPS beat(8)31.44%
EPS beat(12)8
Avg EPS beat(12)38.23%
EPS beat(16)11
Avg EPS beat(16)56.93%
Revenue beat(2)2
Avg Revenue beat(2)1.99%
Min Revenue beat(2)0.94%
Max Revenue beat(2)3.04%
Revenue beat(4)3
Avg Revenue beat(4)1.41%
Min Revenue beat(4)-0.37%
Max Revenue beat(4)3.04%
Revenue beat(8)7
Avg Revenue beat(8)2.35%
Revenue beat(12)9
Avg Revenue beat(12)-4.49%
Revenue beat(16)11
Avg Revenue beat(16)-3.26%
PT rev (1m)-2.2%
PT rev (3m)-5.32%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-3.23%
EPS NY rev (1m)-17.76%
EPS NY rev (3m)-18.7%
Revenue NQ rev (1m)-0.33%
Revenue NQ rev (3m)-1.17%
Revenue NY rev (1m)0.28%
Revenue NY rev (3m)-0.7%
Valuation
Industry RankSector Rank
PE 49.43
Fwd PE 79.67
P/S 4.26
P/FCF N/A
P/OCF 9.61
P/B 1.6
P/tB 1.77
EV/EBITDA 13.24
EPS(TTM)0.35
EY2.02%
EPS(NY)0.22
Fwd EY1.26%
FCF(TTM)-0.19
FCFYN/A
OCF(TTM)1.8
OCFY10.41%
SpS4.06
BVpS10.79
TBVpS9.75
PEG (NY)N/A
PEG (5Y)N/A
Graham Number9.22
Profitability
Industry RankSector Rank
ROA 0.35%
ROE 0.94%
ROCE 2.84%
ROIC 2.24%
ROICexc 2.3%
ROICexgc 2.51%
OM 19.31%
PM (TTM) 2.5%
GM 60%
FCFM N/A
ROA(3y)1.17%
ROA(5y)1.99%
ROE(3y)2.87%
ROE(5y)4.76%
ROIC(3y)2.27%
ROIC(5y)2.16%
ROICexc(3y)2.3%
ROICexc(5y)2.18%
ROICexgc(3y)2.51%
ROICexgc(5y)2.37%
ROCE(3y)2.87%
ROCE(5y)2.73%
ROICexgc growth 3Y5.01%
ROICexgc growth 5Y15.76%
ROICexc growth 3Y4.44%
ROICexc growth 5Y15.37%
OM growth 3Y0.32%
OM growth 5Y7.81%
PM growth 3Y-53.06%
PM growth 5Y-36.91%
GM growth 3Y1.1%
GM growth 5Y2.84%
F-Score6
Asset Turnover0.14
Health
Industry RankSector Rank
Debt/Equity 1.27
Debt/FCF N/A
Debt/EBITDA 5.92
Cap/Depr 130.74%
Cap/Sales 49.05%
Interest Coverage 2.1
Cash Conversion 78.06%
Profit Quality N/A
Current Ratio 0.48
Quick Ratio 0.48
Altman-Z 0.34
F-Score6
WACC6.04%
ROIC/WACC0.37
Cap/Depr(3y)104.54%
Cap/Depr(5y)153.18%
Cap/Sales(3y)38.39%
Cap/Sales(5y)55.21%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0%
EPS 3Y-27.44%
EPS 5Y-16.06%
EPS Q2Q%1500%
EPS Next Y-37.96%
EPS Next 2Y-16.2%
EPS Next 3Y-9.72%
EPS Next 5Y0.77%
Revenue 1Y (TTM)4.52%
Revenue growth 3Y11.05%
Revenue growth 5Y11.4%
Sales Q2Q%3.07%
Revenue Next Year1.94%
Revenue Next 2Y3.03%
Revenue Next 3Y4.42%
Revenue Next 5Y5.62%
EBIT growth 1Y-3.69%
EBIT growth 3Y11.4%
EBIT growth 5Y20.1%
EBIT Next Year254.56%
EBIT Next 3Y58.98%
EBIT Next 5Y35.87%
FCF growth 1Y-137.77%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y16.95%
OCF growth 3Y11.62%
OCF growth 5Y10.54%

HEALTHPEAK PROPERTIES INC / DOC Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for HEALTHPEAK PROPERTIES INC?

ChartMill assigns a fundamental rating of 3 / 10 to DOC.


What is the valuation status for DOC stock?

ChartMill assigns a valuation rating of 1 / 10 to HEALTHPEAK PROPERTIES INC (DOC). This can be considered as Overvalued.


Can you provide the profitability details for HEALTHPEAK PROPERTIES INC?

HEALTHPEAK PROPERTIES INC (DOC) has a profitability rating of 5 / 10.


What is the valuation of HEALTHPEAK PROPERTIES INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for HEALTHPEAK PROPERTIES INC (DOC) is 49.43 and the Price/Book (PB) ratio is 1.6.


How sustainable is the dividend of HEALTHPEAK PROPERTIES INC (DOC) stock?

The dividend rating of HEALTHPEAK PROPERTIES INC (DOC) is 5 / 10 and the dividend payout ratio is 1204.15%.